Amantadin-ratiopharm® 200 mg Infusionslösung clinical trials

AmaNtadine for NeuroenhancEment in acutE patients Study - A prospective pilot proof of concept phase IIb study in intensive and intermediate care unit patients (ANNES)

This study looks at whether a drug called Amantadine can help people with severe brain injury wake up and improve. Researchers will track how patients respond to the treatment over 5 days, checking for signs of improvement in their level of consciousness. It's an early-stage study to see if this treatment shows promise.